No Data
No Data
Morgan Stanley Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $95
Strategic Growth and Expansion of Irhythm Technologies: A Promising Future in Arrhythmia Detection
J.P. Morgan Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $97
IRhythm Technologies Is Maintained at Buy by Canaccord Genuity
CCORF Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $152
Express News | IRhythm Technologies Inc : Canaccord Genuity Raises Target Price to $152 From $125
No Data